Subsequent Events	6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
Subsequent Events	Subsequent Event On July 31, 2026, the Company closed the July 2026 Offering, relating to the issuance and sale by the Company of 21,052,632 shares of its common stock, par value $0.001 per share, and accompanying July 2026 Warrants to purchase up to 42,105,264 shares of its common stock (or Pre-Funded Warrants), at an exercise price of $1.10 per share of common stock (or $1.099 per Pre-Funded Warrant to purchase a share of common stock), at a combined public offering price of $0.95 per share of common stock and accompanying July 2026 Warrant. The Company also granted the Underwriter an option for a period of 30 days to purchase up to 3,157,894 additional shares of common stock and/or July 2026 Warrants to purchase up to 6,315,788 additional shares of common stock (or pre-funded warrants in lieu thereof) at the public offering price, less the underwriting discounts and commissions. On July 29, 2026, the Underwriter exercised such option with respect to the July 2026 Warrants to purchase up to 6,315,788 additional shares of common stock (or pre-funded warrants in lieu thereof). The net proceeds to the Company from the July 2026 Offering, including the exercise of the Underwriter's option to purchase additional warrants, were approximately $18.3 million, after deducting the underwriting discounts and commissions and offering expenses paid and payable by the Company, and assuming no exercise of the Underwriter's option to purchase additional shares.

Subsequent Events

6 Months Ended

Jun. 30, 2026

Subsequent Event

On July 31, 2026, the Company closed the July 2026 Offering, relating to the issuance and sale by the Company of 21,052,632 shares of its common stock, par value $0.001 per share, and accompanying July 2026 Warrants to purchase up to 42,105,264 shares of its common stock (or Pre-Funded Warrants), at an exercise price of $1.10 per share of common stock (or $1.099 per Pre-Funded Warrant to purchase a share of common stock), at a combined public offering price of $0.95 per share of

common stock and accompanying July 2026 Warrant.

The Company also granted the Underwriter an option for a period of 30 days to purchase up to 3,157,894 additional shares of common stock and/or July 2026 Warrants to purchase up to 6,315,788 additional shares of common stock (or pre-funded warrants in lieu thereof) at the public offering price, less the underwriting discounts and commissions. On July 29, 2026, the Underwriter exercised such option with respect to the July 2026 Warrants to purchase up to 6,315,788 additional shares of common stock (or pre-funded warrants in lieu thereof).

The net proceeds to the Company from the July 2026 Offering, including the exercise of the Underwriter's option to purchase additional warrants, were approximately $18.3 million, after deducting the underwriting discounts and commissions and offering expenses paid and payable by the Company, and assuming no exercise of the Underwriter's option to purchase additional shares.